Why Byrna (BYRN) Stock Is Falling Today

Byrna (NASDAQ: BYRN) shares fell 25.8% after the company reported Q2 2026 results that missed expectations. Revenue dropped 42.5% year over year to $16.39 million versus $22.22 million estimates. Byrna posted a GAAP loss of $0.44 per share versus a $0.11 loss consensus and a $0.10 profit a year earlier.

Original reporting
Published Jul 9, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 4:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Byrna (BYRN) Stock Is Falling Today — source image
Decision brief

The 30-second read

$BYRNBearishMed
01

Why it matters

The reported Q2 miss versus Wall Street expectations is the immediate catalyst for the large intraday decline, likely resetting near-term expectations for growth and profitability.

02

Market read

A large earnings-driven gap down suggests traders should reassess valuation and near-term fundamentals, not just technical oversold conditions.

03

What to watch

The article does not provide guidance, backlog, or cash-flow details; traders may need those to judge whether the miss is temporary (timing/channel) or structural (demand/mix).

Relevance 8/10Novelty 8/10Timing: morning session selloff after the company reported Q2 2026 results

Background

Byrna is a non-lethal weapons company whose recent performance included strong growth, but this quarter shows a major revenue decline and GAAP loss reversal.

Company-level read

Ticker impact

$BYRNBearishMedium confidence
Context

Byrna shares fell 25.8% after Q2 revenue dropped 42.5% YoY to $16.39M and GAAP EPS swung to a $0.44 loss vs expectations.

Expected impact

Further volatility likely, with downside pressure until investors get clarity on demand, margins, and path back to growth.

Evidence & confidence

The article cites a large same-day drop tied directly to reported Q2 results missing revenue and EPS consensus, plus a major YoY revenue decline and GAAP loss reversal.

Market effects

Signals heightened scrutiny for non-lethal weapons makers on revenue durability and margin/earnings quality.

No specific regional spillover described.

No global macro or international demand factors cited.

Counterpoint

The stock is already down sharply year-to-date, so some investors may view the selloff as overdone relative to longer-term product and dealer-channel momentum.

Key entities

  • Byrna

    NASDAQ-listed non-lethal weapons company; reported Q2 2026 results that missed revenue and EPS expectations and triggered a steep stock drop.

Related articles

$BYRNMedAI 8/10

Byrna Technologies Inc. (BYRN): Completion of Acquisition or Disposition of Assets

Byrna Technologies Inc. (BYRN) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 2.01. Completion of Acquisition or Disposition of Assets. On August 6, 2026 (the “Closing Date”), Byrna Technologies Inc. (the “Company”) completed its previously announced acquisition (the “Acquisition”) of substantially all of the assets of Hero Defense Systems, LLC, a Nev

$BYRNLow

Why Byrna (BYRN) Shares Are Sliding Today

Byrna (NASDAQ: BYRN) shares fell about 4% after the company appointed James White as Senior VP of Retail and Channel Growth, overseeing retail and e-commerce channels and reporting to CEO Conn Davis. The move follows a sales and marketing realignment. The stock traded near its 52-week low around $3.29, after prior Q2 2026 results missed expectations.

$BYRNMedAI 9/10

Byrna Technologies Q2 Earnings Call Highlights

Byrna Technologies (NASDAQ: BYRN) reported Q2 gross profit of $1.8M (11% of net revenue) versus $17.6M (62%) a year earlier, including $3.6M inventory write-down, $3.5M equipment impairment, and $2.3M inventory reserve. Net loss was $10.1M. Management cited weaker e-commerce conversion and expects no FY2026 revenue growth. Byrna agreed to acquire HERO Defense Systems for $1.25M plus royalties.

$BYRNMed

Byrna Technologies Inc. (BYRN): Results of Operations and Financial Condition

Byrna Technologies Inc. (BYRN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_985847.htm EXHIBIT 99.1 ex_985847.htm Exhibit 99.1 Byrna Technologies Reports Fiscal Second Quarter 2026 Results ANDOVER, Mass., July 9, 2026 - Byrna Technologies Inc. ( “ Byrna ” or the “ Company ” ) (Nasdaq: BYRN) , a personal defense technology company specializin